Addition of formaldehyde releaser imidazolidinyl urea and MOPS buffer to urine samples enables delayed processing for flow cytometric analysis of urinary cells

Kidney diseases are a major health concern worldwide. Currently there is a large unmet need for novel biomarkers to non-invasively diagnose and monitor kidney diseases. Urinary cells are promising biomarkers and their analysis by flow cytometry has demonstrated its utility in diverse clinical settings. However, up to date this methodology depends on fresh samples, as cellular event counts and the signal-to-noise-ratio deter over time. Here we developed an easy-to-use two-step preservation method for conservation of urine samples for subsequent flow cytometry. The protocol utilizes a combination of the formaldehyde releasing agent imidazolidinyl urea (IU) and MOPS buffer, leading to gentle fixation of urinary cells. The preservation method increases acceptable storing time of urine samples from several hours to up to 6 days. Cellular event counts and staining properties of cells remain comparable to fresh untreated samples. The hereby presented preservation method facilitates future investigations on flow cytometry of urinary cells as potential biomarkers and may enable broad implementation in clinical practice.


35
Kidney diseases are among the most common diseases worldwide, affecting an estimated 10 % of the 36 global population (1). Routine laboratory work-up of kidney diseases include serum creatinine, 37 proteinuria and urinary sediment, which yield valuable information about kidney function and 38 potential etiologies of functional impairment. However, the current parameters in use have only 39 limited utility for establishing a diagnosis, predicting outcome and monitoring of treatment response.

40
Kidney biopsy is the current diagnostic gold standard, but is invasive by nature and not free of risk, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. allow broader applicability. Here we report a user-friendly protocol utilizing a combination of pH-56 buffer and formaldehyde-releasing agent, enabling conservation of cells directly in the urine sample.

57
The simple and robust two-step method can easily be performed in less than a minute and enables 58 broader clinical application.

61
Patient cohort . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 16, 2022.

130
Cellular event counts and staining quality decrease over time in untreated urine samples 131 We stored untreated patients' urine samples at 4 °C and analyzed the sediments with flow cytometry 132 at predefined time points, immediately after voiding (fresh) and after 1, 3 and 6 days. Over time, we 133 observed an altered staining quality with reduced signal-to-noise ratios for several analyzed epitopes 134 ( Fig 1A) and a decrease of absolute cellular event counts (Fig 1B). Fixation of cells and tissues with formaldehyde is routine practice in laboratories. Therefore, we next 147 assessed whether this could be applied to urine samples. Addition of formaldehyde (1 %) directly to 148 patients' urine specimen caused precipitation of a gel-like mass (Fig 2A) in 14 of 26 samples after 149 approximately 20 hours at room temperature. This prohibited analysis by flow cytometry. Dipstick 150 testing revealed that precipitate formation was more likely in samples with low pH and increased 151 specific gravity (Fig 2B).

152
In order to buffer urine specimen close to pH 7 we added dissolved, highly concentrated 3-(Morpholin- indicating significant loss/alteration of surface epitopes (Fig 2C). 168 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 16, 2022. intensity was observed despite storage for 6 days (Fig 3).  (Fig 4). Even after storing preserved 190 urine samples for 6 days, we could demonstrate a strong consistency in detected leukocyte counts: T . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Aiming to increase intervals between urine voiding to processing and analysis even further, we stored 209 patient samples treated with the described preservation method at -80 °C for 28 days. After freezing 210 and storage at -80 °C, the flow cytometric staining quality and the quantity of cellular events remained 211 comparable to samples analyzed one day after specimen collection (Fig 5). This was also observed for 212 cell populations not displayed: T cells (CD3+, R = 0.96 (CI 0.50, 1.00), p < 0.05), cytotoxic T lymphocytes . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

233
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. As alternative to formaldehyde we subsequently used imidazolidinyl urea as a fixative -a powdery 249 formaldehyde-releasing agent commonly used in cosmetics as a preservative (24). It slowly releases 250 formaldehyde upon dissolving, which then acts as described above. Using imidazolidinyl urea led to 251 fixation of cells yet preserving epitopes for specific detection. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 16, 2022. staining quality and quantity of detectable cell counts our protocol enables user-friendly sample . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.